Our findings suggest that blocking P-selectin with mAb alleviates renal tubulointerstitial fibrosis, renal hypoxia, and PTC loss without alteration of the levels of lupus activity indicators, anti-dsDNA antibody, or complement C3. Here, C3 is linked to systemic lupus erythematosus.